There was no notable effect of treatment on body weight, BMI, or blood pressure ( More recently, the T2NOW trial compared dapagliflozin and saxagliptin (a dipeptidyl peptidase-4 inhibitor (DPP - 4i)) separately versus a single placebo group
These symptoms could be signs of either low or high potassium levels, both of which require medical attention
Sustained Weight Loss Weight loss continues for over a year and is maintained for at least four years (up to 208 weeks)
A quieter appetite is helpful, but it still requires enough protein, fluids, fiber, and calories to support energy and muscle
The content is not intended to encourage application, diagnosis, or self-treatment of unlicensed individuals, and should not be used as a substitute for the clinical judgment of a qualified healthcare provider